Variant report
Variant | nsv514588 |
---|---|
Chromosome Location | chr11:104924726-104931102 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562441 | chr11:104924786-104924787 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs148991853 | chr11:104924791-104924792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528890226 | chr11:104924807-104924808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143755852 | chr11:104924837-104924838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562452305 | chr11:104924871-104924872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527968387 | chr11:104924902-104924903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182547633 | chr11:104924937-104924938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563562 | chr11:104924938-104924939 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs187159949 | chr11:104924965-104924966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148132350 | chr11:104924966-104924967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12800151 | chr11:104924978-104924979 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs535900780 | chr11:104924995-104924996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12798696 | chr11:104924996-104924997 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs570444593 | chr11:104925041-104925042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546831692 | chr11:104925045-104925046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs547005323 | chr11:104925051-104925052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140211629 | chr11:104925053-104925054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558003841 | chr11:104925100-104925101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568315265 | chr11:104925109-104925110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190429570 | chr11:104925158-104925159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs61893972 | chr11:104925216-104925217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543197800 | chr11:104925245-104925246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538151512 | chr11:104925263-104925264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535363640 | chr11:104925274-104925275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113685586 | chr11:104925292-104925293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546950686 | chr11:104925299-104925300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573396777 | chr11:104925306-104925307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542254925 | chr11:104925316-104925317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374794521 | chr11:104925361-104925362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs474484 | chr11:104925367-104925368 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs572749552 | chr11:104925368-104925369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35255216 | chr11:104925397-104925398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541379124 | chr11:104925408-104925409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569941299 | chr11:104925409-104925410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564765383 | chr11:104925453-104925454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533599716 | chr11:104925478-104925479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550395752 | chr11:104925491-104925492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563814099 | chr11:104925513-104925514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181486946 | chr11:104925593-104925594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150312626 | chr11:104925615-104925616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs137911235 | chr11:104925625-104925626 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs374962760 | chr11:104925644-104925645 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534984650 | chr11:104925685-104925686 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529275144 | chr11:104925693-104925694 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112513343 | chr11:104925701-104925702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549514883 | chr11:104925702-104925703 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147228942 | chr11:104925722-104925723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538435571 | chr11:104925752-104925753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369156339 | chr11:104925781-104925782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536891260 | chr11:104925799-104925800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:104918200-104925200 | Weak transcription | Ovary | ovary |
2 | chr11:104924600-104927000 | Weak transcription | HepG2 | liver |
3 | chr11:104925600-104926400 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr11:104926400-104931600 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
5 | chr11:104927000-104929200 | Enhancers | HepG2 | liver |
6 | chr11:104927000-104936200 | Weak transcription | Small Intestine | intestine |
7 | chr11:104928400-104928800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr11:104929200-104930200 | Weak transcription | HepG2 | liver |
9 | chr11:104931000-104931200 | Enhancers | HepG2 | liver |
10 | chr11:104931000-104936800 | Weak transcription | Primary T helper cells fromperipheralblood | blood |